Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China

References

• Tian X, Zheng X, Sun Y, et al. Molecular mechanisms and epidemiology of carbapenem-resistant Escherichia coli isolated from Chinese patients during 2002–2017. Infect Drug Resist. 2020;13:501–512.32110061
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Abrok M, Lazar A, Burian K. Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-year surveillance study. Medicina (Kaunas). 2019;55(7).
   Web of Science ®Google Scholar
• Behzadi P, Urban E, Gajdacs M. Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020;8(2):17. doi:10.3390/diseases8020017
   Web of Science ®Google Scholar
• Flament-Simon SC, de Toro M, Mora A, et al. Whole genome sequencing and characteristics of mcr-1-harboring plasmids of porcine Escherichia coli isolates belonging to the high-risk clone O25b: H4-ST131Clade B. Front Microbiol. 2020;11:387. doi:10.3389/fmicb.2020.0038732265859
   PubMed Web of Science ®Google Scholar
• Caniaux I, van Belkum A, Zambardi G, Poirel L, Gros MF. MCR: modern colistin resistance. Eur J Clin Microbiol Infect Dis. 2017;36(3):415–420. doi:10.1007/s10096-016-2846-y27873028
   PubMed Web of Science ®Google Scholar
• Cai Y, Lee W, Kwa AL. Polymyxin B versus colistin: an update. Expert Rev Anti Infect Ther. 2015;13(12):1481–1497. doi:10.1586/14787210.2015.109393326488563
   PubMed Web of Science ®Google Scholar
• Phan MD, Nhu NTK, Achard MES, et al. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli. J Antimicrob Chemother. 2017;72(10):2729–2736. doi:10.1093/jac/dkx20429091192
   PubMed Web of Science ®Google Scholar
• Shen C, Feng S, Chen H, et al. Transmission of mcr-1-producing multidrug-resistant enterobacteriaceae in public transportation in Guangzhou, China. Clin Infect Dis. 2018;67(suppl_2):S217–S224. doi:10.1093/cid/ciy66130423047
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Xavier BB, Lammens C, Ruhal R, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium. Euro Surveill. 2016;21(27). doi:10.2807/1560-7917.ES.2016.21.27.30280
   Google Scholar
• Yin W, Li H, Shen Y, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. mBio. 2017;8(3).
   Web of Science ®Google Scholar
• Gajdacs M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar
• Li J, Rayner CR, Nation RL, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006;50(9):2946–2950. doi:10.1128/AAC.00103-0616940086
   PubMed Web of Science ®Google Scholar
• Lin J, Xu C, Fang R, et al. Resistance and heteroresistance to colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China. Antimicrob Agents Chemother. 2019;63(10). doi:10.1128/AAC.00556-19
   Web of Science ®Google Scholar
• Charretier Y, Diene SM, Baud D, et al. Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii. Antimicrob Agents Chemother. 2018;62(9).
   Web of Science ®Google Scholar
• Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS. Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection. mBio. 2018;9(2).
   Web of Science ®Google Scholar
• Hong YK, Ko KS. PmrAB and PhoPQ variants in colistin-resistant enterobacter spp. isolates in Korea. Curr Microbiol. 2019;76(5):644–649. doi:10.1007/s00284-019-01672-130891622
   PubMed Web of Science ®Google Scholar
• Chen L, Lin J, Lu H, et al. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China. J Antibiot (Tokyo). 2020.
   Web of Science ®Google Scholar
• Telke AA, Olaitan AO, Morand S, Rolain JM. soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump. J Antimicrob Chemother. 2017;72(10):2715–2721. doi:10.1093/jac/dkx21529091215
   PubMed Web of Science ®Google Scholar
• Silva A, Sousa AM, Alves D, Lourenco A, Pereira MO. Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms. Pathog Dis. 2016;74(5). doi:10.1093/femspd/ftw036
   Web of Science ®Google Scholar
• El-Halfawy OM, Valvano MA. Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells. PLoS One. 2013;8(7):e68874.23844246
   PubMed Web of Science ®Google Scholar
• Juhasz E, Ivan M, Pinter E, Pongracz J, Kristof K. Colistin resistance among blood culture isolates at a tertiary care centre in Hungary. J Glob Antimicrob Resist. 2017;11:167–170. doi:10.1016/j.jgar.2017.08.00228838854
   PubMed Web of Science ®Google Scholar
• Gajdács M, Ábrók M, Lázár A, Burián K. Differential epidemiology and antibiotic resistance of lactose-fermenting and non-fermenting Escherichia coli: is it just a matter of taste? Biol Futur. 2020;71(1–2):175–182. doi:10.1007/s42977-020-00016-6
   Google Scholar
• The European committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of mics and zone diameters. version 9.0; 2019 Available from: http://www.eucast.org. Accessed 923, 2020.
   Google Scholar
• Bergen PJ, Forrest A, Bulitta JB, et al. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. Antimicrob Agents Chemother. 2011;55(11):5134–5142. doi:10.1128/AAC.05028-1121876058
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100 Wayne, PA: Clinical and Laboratory Standards Institute; 2019
   Google Scholar
• Spengler G, Kincses A, Gajdacs M, Amaral L. New roads leading to old destinations: efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules. 2017;22.
   Web of Science ®Google Scholar
• Cao L, Li X, Xu Y, Shen J. Prevalence and molecular characteristics of mcr-1 colistin resistance in Escherichia coli: isolates of clinical infection from a Chinese University hospital. Infect Drug Resist. 2018;11:1597–1603.30310295
   PubMed Web of Science ®Google Scholar
• Xavier BB, Lammens C, Ruhal R, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium. Euro Surveill. 2016;21.
   Google Scholar
• Rebelo AR, Bortolaia V, Kjeldgaard JS, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill. 2018;23.
   Google Scholar
• Luo Q, Yu W, Zhou K, et al. Molecular epidemiology and colistin resistant mechanism of mcr-positive and mcr-negative clinical isolated Escherichia coli. Front Microbiol. 2017;8:2262. doi:10.3389/fmicb.2017.0226229250039
   PubMed Web of Science ®Google Scholar
• Baron SA, Rolain JM. Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and gram-negative bacteria. J Antimicrob Chemother. 2018;73(7):1862–1871. doi:10.1093/jac/dky13429718423
   PubMed Web of Science ®Google Scholar
• Chabou S, Leangapichart T, Okdah L, Le Page S, Hadjadj L, Rolain JM. Real-time quantitative PCR assay with Taqman((R)) probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. New Microbes New Infect. 2016;13:71–74. doi:10.1016/j.nmni.2016.06.01727489722
   PubMedGoogle Scholar
• Hankins JV, Madsen JA, Needham BD, Brodbelt JS, Trent MS. The outer membrane of gram-negative bacteria: lipid A isolation and characterization. Methods Mol Biol. 2013;966:239–258.23299739
   PubMedGoogle Scholar
• Dortet L, Bonnin RA, Pennisi I, et al. Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. J Antimicrob Chemother. 2018;73(12):3359–3367.30184212
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643. doi:10.3389/fmicb.2014.0064325505462
   PubMed Web of Science ®Google Scholar
• Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019;17(8):479–496. doi:10.1038/s41579-019-0218-131235888
   PubMed Web of Science ®Google Scholar
• Lu H, Wang C, Dong G, et al. Prevalence and molecular characterization of Escherichia coli clinical isolates carrying mcr-1 in a Chinese teaching hospital from 2002–2016. Antimicrob Agents Chemother. 2018;62(9). doi:10.1128/AAC.02623-17
   Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plesiat P. Resistance to polymyxins in gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526–535. doi:10.1016/j.ijantimicag.2016.11.02928163137
   PubMed Web of Science ®Google Scholar
• Shen Y, Wu Z, Wang Y, et al. Heterogeneous and flexible transmission of mcr-1 in hospital-associated Escherichia coli. mBio. 2018;9(4). doi:10.1128/mBio.00943-18
   Web of Science ®Google Scholar
• Daly SM, Sturge CR, Felder-Scott CF, Geller BL, Greenberg DE, Bonomo RA. MCR-1 inhibition with peptide-conjugated phosphorodiamidate morpholino oligomers restores sensitivity to polymyxin in Escherichia coli. mBio. 2017;8(6). doi:10.1128/mBio.01315-17
   Web of Science ®Google Scholar
• Bulman ZP, Chen L, Walsh TJ, et al. Polymyxin combinations combat Escherichia coli harboring mcr-1 and blaNDM-5: preparation for a postantibiotic era. mBio. 2017;8(4). doi:10.1128/mBio.00540-17
   Web of Science ®Google Scholar
• Zhuge X, Ji Y, Tang F, et al. Population structure and antimicrobial resistance traits of avian-origin mcr-1-positive Escherichia coli in Eastern China, 2015 to 2017. Transbound Emerg Dis. 2019;66(5):1920–1929. doi:10.1111/tbed.1322231059196
   PubMed Web of Science ®Google Scholar
• Mediavilla JR, Patrawalla A, Chen L, et al. Colistin- and carbapenem-resistant Escherichia coli harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States. mBio. 2016;7(4). doi:10.1128/mBio.01191-16
   Web of Science ®Google Scholar
• Hawley JS, Murray CK, Jorgensen JH. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother. 2008;52(1):351–352.17954699
   PubMed Web of Science ®Google Scholar
• El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28(1):191–207. doi:10.1128/CMR.00058-1425567227
   PubMed Web of Science ®Google Scholar
• Quesada A, Porrero MC, Tellez S, Palomo G, Garcia M, Dominguez L. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. J Antimicrob Chemother. 2015;70(1):71–74. doi:10.1093/jac/dku32025150146
   PubMed Web of Science ®Google Scholar
• Poole K, Lau CH, Gilmour C, Hao Y, Lam JS. Polymyxin susceptibility in Pseudomonas aeruginosa linked to the MexXY-OprM multidrug efflux system. Antimicrob Agents Chemother. 2015;59(12):7276–7289. doi:10.1128/AAC.01785-1526369970
   PubMed Web of Science ®Google Scholar
• Perez A, Poza M, Fernandez A, et al. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother. 2012;56(4):2084–2090. doi:10.1128/AAC.05509-1122290971
   PubMed Web of Science ®Google Scholar
• Machado D, Antunes J, Simoes A, et al. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate. J Med Microbiol. 2018;67(6):740–749. doi:10.1099/jmm.0.00074129717972
   PubMed Web of Science ®Google Scholar
• Mitchell P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biochim Biophys Acta. 2011;1807(12):1507–1538. doi:10.1016/j.bbabio.2011.09.01822082452
   PubMed Web of Science ®Google Scholar
• Leung LM, Fondrie WE, Doi Y, et al. Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids. Sci Rep. 2017;7(1):6403. doi:10.1038/s41598-017-04793-428743946
   PubMed Web of Science ®Google Scholar
• Powers MJ, Herrera CM, Tucker AT, Davies BW, Trent MS. Isolation of lipid cell envelope components from Acinetobacter baumannii. Methods Mol Biol. 2019;1946:233–252.30798560
   PubMedGoogle Scholar
• Sun J, Xu Y, Gao R, et al. Deciphering MCR-2 colistin resistance. mBio. 2017;8(3).
   Web of Science ®Google Scholar